Osteoarthritis Clinical Trial
— TARVAOfficial title:
A Randomised, Multi-centre, Non-blinded, Prospective, Parallel Group Trial of Total Ankle Replacement (TAR) Versus Ankle Arthrodesis in Patients With End Stage Ankle Osteoarthritis, Comparing Clinical Outcomes and Cost-effectiveness.
Verified date | March 2021 |
Source | University College, London |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of TARVA is to determine whether Total Ankle Replacement (TAR) provides better clinical outcomes than ankle arthrodesis in patients aged 50-85 years with end-stage ankle osteoarthritis, and compare cost-effectiveness of the two treatments
Status | Active, not recruiting |
Enrollment | 303 |
Est. completion date | February 28, 2029 |
Est. primary completion date | December 23, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 50 Years to 85 Years |
Eligibility | Inclusion Criteria: - Diagnosis of end-stage ankle osteoarthritis - Aged 50-85 years inclusive - The surgeon believes the patient is suitable for both TAR and arthrodesis (having considered deformity, stability, bone quality, soft tissue envelope, and neurovascular status) - The patient is able to read and understand the Patient Information Sheet (PIS) and trial procedures - The patient is willing and able to provide written informed consent Exclusion Criteria: - Previous ipsilateral talonavicular, subtalar or calcaneocuboid fusion or surgery planned within 1 year of index procedure - More than 4 lower limb joints fused (including contralateral limb, but excluding proximal interphalangeal joint fusions) - • Unable to have MRI/CT scan (e.g. severe claustrophobia or contraindication for either scan) - History of local bone or joint infection - Any co-morbidity, which, in the opinion of the investigator, is severe enough to; interfere with the patient's ability to complete the study assessments or; presents an unacceptable risk to the patient's safety - Participant in another clinical trial that would materially impact on their participation in this study |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Brighton & Sussex University Hospitals NHS Trust | Brighton | |
United Kingdom | North Bristol NHS Trust | Bristol | |
United Kingdom | Cardiff and Vale Orthopaedic Centre | Cardiff | |
United Kingdom | Royal Derby Hospital | Derby | |
United Kingdom | Royal Surrey County Hospital | Guildford | |
United Kingdom | Hull and East Yorkshire Hospitals NHS Trust | Hull | |
United Kingdom | Aintree University Hospital | Liverpool | |
United Kingdom | Freeman Hospital | Newcastle | |
United Kingdom | Northumbria Healthcare NHS Foundation Trust | Newcastle | |
United Kingdom | Norfolk and Norwich University Hospitals NHS Foundation Trust | Norwich | |
United Kingdom | Nottingham University Hospitals NHS Trust | Nottingham | |
United Kingdom | Robert Jones & Agnes Hunt Orthopaedic Hospital | Oswestry | |
United Kingdom | Oxford University Hospitals NHS Foundation Trust | Oxford | |
United Kingdom | Northern General Hospital | Sheffield | |
United Kingdom | Royal National Orthopaedic Hospital NHS Trust | Stanmore | |
United Kingdom | Royal Cornwall Hospitals NHS Trust | Truro | Cornwall |
United Kingdom | Wrightington Hospital | Wigan |
Lead Sponsor | Collaborator |
---|---|
University College, London | National Institute for Health Research, United Kingdom |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Self-reported pain-free function domain score | To compare the improvement in self-reported pain-free function domain score from pre-op to 52 weeks post-op for TAR versus arthrodesis, assessed by MOXFQ walking/standing domain scores. | Pre-operation (baseline) to 52 weeks | |
Secondary | Self-reported pain-free function domain score | To compare the improvement in self-reported pain-free function domain score from pre-op to 26 weeks post-op for TAR versus arthrodesis, assessed by MOXFQ walking/standing domain scores. | Pre-operation (baseline) to 26 weeks | |
Secondary | Self-reported pain and social interaction domain score | To compare the improvement in self-reported pain and social interaction domain scores from pre-op to 26 and 52 weeks post-op for TAR versus arthrodesis, assessed by MOXFQ. | Pre-operation (baseline) to 26 and 52 weeks | |
Secondary | Self-reported physical function | To compare the improvement in self-reported physical function from pre-op to 26 and 52 weeks post-op of TAR versus arthrodesis, assessed by the Foot and Ankle Ability Measure (FAAM) questionnaire. | Pre-operation (baseline) to 26 and 52 weeks | |
Secondary | Self-reported quality of life | To compare the improvement in QoL from pre-op to 26 and 52 weeks post-op of TAR versus arthrodesis, assessed by EQ-5D. | Pre-operation (baseline) to 26 and 52 weeks | |
Secondary | Range of Motion | To compare the change in total ROM (plantarflexion and dorsiflexion) from pre-op to 52 weeks post-op of TAR versus arthrodesis, assessed by goniometer. | Pre-operation (baseline) to 52 weeks | |
Secondary | Adverse events | To compare the safety of TAR versus arthrodesis in terms of complications and adverse events. | 52 weeks | |
Secondary | Incremental cost and cost-effectiveness | To compare the incremental cost and cost-effectiveness of TAR versus arthrodesis by recording cost of all components and procedure-related costs for each surgical treatment, and using self-reported data from the Health and Social Care Services Use questionnaire. | 52 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04657926 -
A Trial of APPA in the Treatment of Knee Osteoarthritis
|
Phase 2 | |
Completed |
NCT02536833 -
A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects
|
Phase 2 | |
Completed |
NCT03014037 -
Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration
|
N/A | |
Recruiting |
NCT05937542 -
A Qualitative Investigation of CLEAT Participants
|
||
Completed |
NCT03644615 -
A Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT06061367 -
Muscles Strength and Gait Parameteres After TKA
|
||
Withdrawn |
NCT04976972 -
A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03850665 -
Comparison of Functional Outcome in Patients After Hip Arthroplasty Depending on Surgical Approach
|
N/A | |
Completed |
NCT02826902 -
Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial
|
N/A | |
Completed |
NCT04402502 -
Dynamic 4DCT to Examine Wrist Carpal Mechanics
|
N/A | |
Completed |
NCT02923700 -
Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial
|
Phase 4 | |
Completed |
NCT04564053 -
Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants
|
Phase 1 | |
Completed |
NCT05070871 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women
|
N/A | |
Not yet recruiting |
NCT05036174 -
Diphenhydramine Ointment for Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT02666443 -
Low Dose Dexamethasone in Supraclavicular Blocks
|
N/A | |
Recruiting |
NCT02912429 -
Onlay vs. Inlay Patellofemoral Arthroplasty
|
N/A | |
Active, not recruiting |
NCT02723929 -
Effects of tDCS and tUS on Pain Perception in OA of the Knee
|
||
Terminated |
NCT02820766 -
Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting
|
N/A | |
Withdrawn |
NCT02921594 -
Kinematic Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties
|
N/A |